# Filing Detail

Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001437749-24-012384
Filing Date
2024-04-18
Accepted
2024-04-18 09:00:58
Documents
27
Period of Report
2024-05-28

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | FORM DEF 14A | nby20240411_def14a.htm iXBRL | DEF 14A | 897473
6 |  | comp.jpg | GRAPHIC | 59755
7 |  | diversity.jpg | GRAPHIC | 65975
8 |  | i01.jpg | GRAPHIC | 766
9 |  | i02.jpg | GRAPHIC | 770
10 |  | i04.jpg | GRAPHIC | 794
11 |  | nby20240404_pre14aimg001.jpg | GRAPHIC | 5110
12 |  | nby20240404_pre14aimg002.jpg | GRAPHIC | 5110
13 |  | nby20240404_pre14aimg003.jpg | GRAPHIC | 5110
14 |  | pry01.jpg | GRAPHIC | 199279
15 |  | pry02.jpg | GRAPHIC | 151895
16 |  | sig1.jpg | GRAPHIC | 6351
17 |  | sig2.jpg | GRAPHIC | 7623
18 |  | tsr.jpg | GRAPHIC | 55838
| Complete submission text file | 0001437749-24-012384.txt |  | 3039496

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
2 | XBRL TAXONOMY EXTENSION SCHEMA | nby-20231231.xsd | EX-101.SCH | 6045
3 | XBRL TAXONOMY EXTENSION DEFINITION LINKBASE | nby-20231231_def.xml | EX-101.DEF | 7207
4 | XBRL TAXONOMY EXTENSION LABEL LINKBASE | nby-20231231_lab.xml | EX-101.LAB | 13914
5 | XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE | nby-20231231_pre.xml | EX-101.PRE | 7010
30 | EXTRACTED XBRL INSTANCE DOCUMENT | nby20240411_def14a_htm.xml | XML | 151603

Mailing Address 2000 POWELL STREET, SUITE 1150 EMERYVILLE CA 94608
Business Address 2000 POWELL STREET, SUITE 1150 EMERYVILLE CA 94608 (510) 899-8800
NovaBay Pharmaceuticals, Inc. (Filer) CIK: 0001389545 (see all company filings)

EIN.: 680454536 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-33678 | Film No.: 24853004
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)